KEV Entry

CVE-2026-123218

Known Exploited Vulnerability Entry Previdian

Entry Details
Confirmed Exploited

CVE-2026-123218

2026-11-09 20:40 UTC


Timestamps

2026-11-09

2026-11-09


Scope

IBM Aspera Faspex Authorization Bypass | Affected: IBM / Aspera Faspex | CVSS: 9.8 (CRITICAL) | EPSS: 0.00396 | Used in malware: unknown | Not yet in CISA KEV: False


References
  • {'id': 'CVE-2026-123218', 'url': 'https://www.cve.org/CVERecord?id=CVE-2026-123218'}
  • {'id': 'previdian', 'url': 'https://previdian.com/CVE-2026-123218'}

47d3a0c5-9c77-477a-b364-61248b958365

Previdian
caeb2787-0d58-4236-9039-7c86c3e566f3

2026-11-10 21:00 UTC

2026-11-10 21:00 UTC

Evidence
1
Type Source Signal Confidence Details GCVE Metadata
public_report previdian successful_exploitation 0.70
View details
{
  "added_date": "2026-11-09T20:40:21.750Z",
  "ahead_of_cisa_kev": null,
  "cve_id": "CVE-2026-123218",
  "cvss_estimated": false,
  "cvss_score": 9.8,
  "cvss_severity": "CRITICAL",
  "epss_percentile": 0.34123,
  "epss_score": 0.00396,
  "feed": "Previdian (previdian.com)",
  "ghsa_id": null,
  "not_yet_in_cisa_kev": false,
  "previous_ids": [],
  "product": "Aspera Faspex",
  "title": "IBM Aspera Faspex Authorization Bypass",
  "used_in_malware": "unknown",
  "vendor": "IBM",
  "virtual_patch": false,
  "vulnerability_id": "CVE-2026-123218"
}
-